U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07319377) titled 'Evaluation of Safety and Efficacy of a Digital Therapeutic Device to Improve Strength in Sarcopenia (Sarc-DTx)' on Nov. 20, 2025.
Brief Summary: This clinical trial aims to demonstrate that the use of a digital therapeutic device (exoDTx) in patients with sarcopenia is superior to self-exercise in terms of muscle strength improvement and safety.
Study Start Date: Nov. 28, 2025
Study Type: INTERVENTIONAL
Condition:
Sarcopenia
Intervention:
DEVICE: exoDTx
Experimental group (exoDTx): After baseline on-site training, participants perform personalized resistance exercises at home using a mobile app >=3 times/week, 50 min/session, ...